Literature DB >> 20067866

Studies on the chemical composition of kohl stone by X-ray diffractometer.

Pervaiz Habib Ullah1, Zafar Alam Mahmood, Mohammad Sualeh, S M S Zoha.   

Abstract

Use of Kohl (Surma) creates toxicity or protects eye, is one of the most controversial topic of modern medicines. However, modern researches show that kohl forms a thin film on the eye lens thus avoiding the direct contract of harmful UV radiation and glare of sun with lens. Black and shining particles of galena in kohl shield the eyes from glare and reflection of sun and thus protect them from harmful effect of UV radiation emerging from the sun. Based on these findings and other properties of kohl, it was decided to undertake this study to ascertain it's chemical composition and to correlate these properties scientifically. In the present study, kohl stone obtained from Madina (Saudi Arabia) was analyzed to ascertain it's chemical composition. The chemical analysis and X-ray diffractometer results obtained, showed that the main component of kohl stone is galena (PbS).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20067866

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  4 in total

1.  Fluorescent Carbon Dots Prepared from Hazelnut Kohl as an Affordable Probe for Determination of Dopamine.

Authors:  Neda Chavoshi; Bahram Hemmateenejad
Journal:  J Fluoresc       Date:  2021-01-08       Impact factor: 2.217

2.  Toxic Elements in Traditional Kohl-Based Eye Cosmetics in Spanish and German Markets.

Authors:  Elisabet Navarro-Tapia; Mariona Serra-Delgado; Lucía Fernández-López; Montserrat Meseguer-Gilabert; María Falcón; Giorgia Sebastiani; Sebastian Sailer; Oscar Garcia-Algar; Vicente Andreu-Fernández
Journal:  Int J Environ Res Public Health       Date:  2021-06-05       Impact factor: 3.390

3.  Recipes of Ancient Egyptian kohls more diverse than previously thought.

Authors:  Marabel Riesmeier; Jennifer Keute; Margaret-Ashley Veall; Thibaut Devièse; Daniel Borschneck; Alice Stevenson; Anna Garnett; Alice Williams; Maria Ragan
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

4.  The Efficacy of Kohl (Surma) and Erythromycin in Treatment of Blepharitis: An Open-Label Clinical Trial.

Authors:  Esmat Karbassi; Ehsan Amiri-Ardekani; Alireza Farsinezhad; Armita Shahesmaeili; Yasaman Abhari; Mahsa Ziaesistani; Noushin Pouryazdanpanah; Ali Derakhshani; Fatemeh Jamshidi; Haleh Tajadini
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-24       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.